InvestWiser

Nanologica AB

NICANasdaq StockholmHealthcareMarket value 54 m SEK
0.16SEK −0.3%
last day · Price as of 20 November 2026

The answer first

Does Nanologica beat the market?

No, Nanologica has not beaten the market over the last year.

Nanologica−83.7%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 72% of Nordic stocks

    • Quality86
    • Value99
    • Trend1

    No. 35 of 195 in healthcare

Max for seven days

Follow Nanologica with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Nanologica

From today, at a price of 0.16 SEK. Write why you follow Nanologica, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Nanologica

Your first answer is free, no account needed.

Do you own Nanologica, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Nanologica and a few more. Free, no card.

Past year against the exchange and Super Stock
Nanologica−83.7%Stockholm (OMXSGI)+17.6%Super Stock+46.4%
19 November 202520 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Nanologica has fallen 83.7% over the past year, including dividends.
  • Overall, Nanologica ranks better than 72% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 98.5%. The price is 99.3% below its peak now.

What do analysts think of Nanologica?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

72

Quality, value and trend together. Better than 72% of Nordic stocks.

No. 35 of 195 in healthcare

Quality86
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 42 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.41
  • Asset turnoverSales divided by everything the company owns0.22
  • Return on equityProfit divided by equity+12.0%
  • Cash conversionOperating cash flow divided by profit−3.03

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value99
The price · Valuation: the multiples

High Low price: you pay little for what the company earns and owns.

No. 3 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity0.3
  • P/SPrice divided by sales0.9
  • P/EPrice divided by earnings2.4
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend1
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 191 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−61.0%
  • 6 months−75.1%
  • 9 months−58.5%
  • 12 months−83.7%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−34.2%
3 years, per year
−73.6%
5 years, per year
−57.4%
10 years, per year
−36.5%
Largest fall, 3 years
−98.5%
From a peak to the bottom
From the peak now
−99.3%
How far the price is from the peak
Volatility, 1 year
144.0%
How much the price swings over a year
Beta, 1 year
1.19
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Nanologica

2 funds we follow own Nanologica. The share is how much of the fund the stock makes up.

  • Sweden2

From the funds' latest known holdings.

About Nanologica

Nanologica AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Nanologica is number 107 of 137 companies in healthcare on Nasdaq Stockholm. Nanologica has not paid a dividend in the past twelve months. Of the three measures in the ranking, Nanologica is strongest on value, better than 99% of Nordic stocks. The share trades in SEK. It has around 72 employees.

Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-based purification media for preparative chromatography that is developed for the purification of peptide drugs, such as insulin and GLP-1 analogues; NLAB Idun, an ion exchange product for robust, reproducible, and efficient downstream purification of GLP-1 analogues and other peptides; NLAB Idun SP, a strong cation exchanger with sulfopropyl groups as ligands; NLAB Idun Q, a strong anion exchanger with a quaternary amine ligand; and NLAB Siv, a non-silica-based media for purif…

See the full analysis of Nanologica.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market